Press Releases

DURHAM, N.C., Dec. 5, 2019 /PRNewswire/ -- 410 Medical, a medical device company developing innovative technologies for critical care, has been awarded a group purchasing agreement for Emergency Medicine Products with Premier, Inc. Effective October 1, 2019, the new agreement allows Premier members, at their discretion, to take advantag

LUSAKA, Zambia, Dec. 5, 2019 /PRNewswire/ -- Starkey Hearing Foundation, a Minnesota-based nonprofit organization committed to mak

CAMBRIDGE, Mass. and NEW YORK, Dec. 5, 2019 /PRNewswire/ -- Black Diamond Therapeutics, Inc., a precision oncology medicine company pioneering the discovery and development of small molecule, tumor-agnostic therapies, today announced the completion of an oversubscribed Series C financing of $85 million l

TORONTO, Dec. 5, 2019 /PRNewswire/ -  Liberty Health Sciences Inc. (CSE: LHS) (OTCQX: LHSIF)

BOSTON, Dec. 5, 2019 /PRNewswire/ -- PatientPing, the nation's leading care collaboration network, today announced the launch of two new products, Callouts and Spotlights, to its enterprise care collaboration suite. With an enterprise product suite of Pings, Stories, Callouts, and Spotlights, care teams across the continuum will get unprecedented real-time workflow guida

IRVINE, Calif., Dec. 5, 2019 /PRNewswire/ -- SmartBug Media®—a leading Intelligent Inbound® marketing agency that assists businesses in generating leads, increasing awaren

WASHINGTON, Dec. 5, 2019 /PRNewswire/ -- The Center for Innovative GYN Care® (CIGC®) co-founders, Dr. Paul MacKoul and

HENDERSON, Nev., Dec. 5, 2019 /PRNewswire/ -- Dalrada Health, a wholly-owned subsidiary of Dalrada Financial Corp. (OTC Pink: DFCO), recently announced the filing of a provisional patent in India for their product designed to screen for cervical cancer. The company intends to file its innovative product with the United States Patent

CARLSBAD, Calif., Dec. 5, 2019 /PRNewswire/ -- Clinical researchers who take a traditional sequential approach to analyze myeloid malignancies, a highly heterogeneous group of disorders, face a major hurdle: a laborious and time-consuming workflow. To simplify and accelerate the genomic profiling process, Thermo Fisher Scientific announced that the Ion Torrent

OAKLAND, Calif., Dec. 5, 2019 /PRNewswire/ -- Kaiser Permanente Ventures (KPV) today announced it has closed its fifth investment fund at $141 million, bringing the total assets under management to more than $500 million. This latest fund includes financial commitments from Kaiser Permanente and a diverse g